IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 1,042,000 (47%) | — | ₹313 Cr |
| Retail | — | 1,042,000 (47%) | — | ₹313 Cr |
| Market Maker | — | 112,000 (5%) | — | ₹3 Cr |
| Σ Total | — | 2,196,000 (100%) | — | ₹6,588 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹120,000 |
| Retail (Max) | 13 | 52,000 | ₹1,560,000 |
| S-HNI (Min) | 14 | 56,000 | ₹1,680,000 |
| B-HNI (Min) | 67 | 268,000 | ₹8,040,000 |
Financial Statements Amount in ₹ Lakhs
| Metric | 31-Aug-2017 | 31-Mar-2017 | 31-Mar-2016 |
|---|---|---|---|
| Revenue | 1,394 | 2,858 | 1,323 |
| Profit After Tax | 16 | 28 | 10 |
| Total Assets | 1,564 | 1,286 | 243 |
| Reserves & Surplus | 47 | 64 | 29 |
| Total Borrowing | 524 | 507 | 78 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- To part finance working capital requirements of the Company – 4.99
- General corporate purposes – 1.16
Company Overview
Incorporated in 2010, Ajooni Biotech Limited is Mohali, Punjab based company engaged in manufacturing, producing, processing and supplying of Cattle feed, Nutrients related to cattle feed and manufacturing & production of Animal health care supplements.
Ajooni Biotech have entered into an Agreement with Patanjali for manufacturing of Cattle feed and Distribution of Cattle feed and feed supplements in under brand name Patanjali in the states of Punjab, Himachal Pradesh, some parts of Jammu & Kashmir, Haryana and Rajasthan. Ajooni Biotech is manufacturer and supplier of Patanjali Samvriddhi, Patanjali Garbhanjali, Patanjali Batisa-pro etc brands.
Company also manufacture cattle feed & supplement under own brand name of "AUTUS Animal Healthcare".